Abstract

Methods for identifying a therapeutic agent for treating a Germinal Center Kinase (GCK)-Like Kinase (GLK)-mediated disease are disclosed. Methods for detecting a modulation of GLK signaling by a lest compound are disclosed. Also disclosed are methods for detecting the presence and/or severity of an autoimmune disease and/or cancer.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jan 17, 2013
  • Application: Jul 13, 2012
    US US 201213548212 A
  • Priority: Jul 13, 2012
    US US 201213548212 A
  • Priority: Jul 14, 2011
    US US 201161508057 P

Download Citation


Sign in to the Lens

Feedback